http://www.denverpost.com/ci_14871656 To 62-year-old Hal Kaye, the injection of
his own stem cells into his battered ankle was a miracle cure that saved him from debilitating surgery.
To the Food and Drug Administration, the treatment pioneered by a Broomfield doctor appears to be a misuse of a drug that requires licensing and federal scrutiny before it's used on patients.
And that puts Dr. Chris Centeno on the front line of a simmering dispute over the use and regulation of adult stem cells, which can be cast as either a rogue therapy or breakthrough panacea.
Centeno says his procedure — Regenexx — is one of the first in the U.S. to bridge the gap between stem-cell research and actual treatment. Regenexx involves harvesting a patient's cells from bone marrow, growing more in a lab and then injecting the tissue-repairing cells into damaged joints or even lumbar discs.
http://www.denverpost.com/ci_14871656 Seems that if Pharmaceuticals cant make profit from a procedure (that works) they are against it. Regardless of the benefits to the patient.
The other aspect of this is that the stem cells used are NOT from fetal tissue. but from the individual patient.